Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Stroke. 2018 Nov;49(11):2652–2658. doi: 10.1161/STROKEAHA.118.021799

Table 3.

Multivariable Analyses of Recovery after Oral Anticoagulation ICH

Variable Functional Recovery*
RETRACE MGH ERICH All Studies
OR
(95% CI)
p OR
(95% CI)
p OR
(95% CI)
p OR
(95% CI)
p
CHA2DS2-VASc Score
(for 1 point increase)
0.85
(0.73 – 0.99)
0.036 0.78
(0.59 – 1.02)
0.075 0.84
(0.68 – 1.04)
0.11 0.83
(0.79 – 0.86)
<0.001
OAT Resumption 1.88
(1.05 – 3.37)
0.035 2.10
(1.04 – 4.25)
0.041 1.77
(0.98 – 3.19)
0.061 1.89
(1.32 – 2.70)
<0.001
Variable mRS Score Change**
RETRACE MGH ERICH All Studies
OR (95% CI) p OR
(95% CI)
p OR
(95% CI)
p OR
(95% CI)
p
CHA2DS2-VASc Score
(for 1 point increase)
0.90
(0.83 – 0.98)
0.012 0.82
(0.70 – 0.96)
0.013 0.85
(0.74 – 0.98)
0.025 0.88
(0. 82 – 0.93)
<0.001
OAT Resumption 1.66
(1.10 – 2.51)
0.017 1.77
(1.13 – 2.77)
0.014 1.58
(1.06 – 2.36)
0.027 1.66
(1.30 – 2.12)
<0.001

All analyses adjusted for discharge modified Rankin scale, ICH location, and exposure to antiplatelet agents.

*

defined as achieving mRS ≤3 if mRS > 3 at discharge

**

difference in mRS score between one-year follow-up and discharge, effect size calculated for one-point decrease in mRS

Abbreviations: 95% CI = 95% Confidence Interval, mRS = modified Rankin scale, OAT = Oral Anticoagulation Treatment, OR = Odds Ratio.